A citation-based method for searching scientific literature

Luca Arcaini, Davide Rossi, Marco Paulli. Blood 2016
Times Cited: 89







List of co-cited articles
692 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Davide Rossi, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, Silvia Rasi, Valeria Spina, Sara Monti, Tiziana Vaisitti, Francesca Arruga, Rosella Famà,[...]. J Exp Med 2012
261
28

Splenic marginal zone lymphoma: a prognostic model for clinical use.
Luca Arcaini, Mario Lazzarino, Nora Colombo, Sara Burcheri, Emanuela Boveri, Marco Paulli, Enrica Morra, Marcello Gambacorta, Sergio Cortelazzo, Alessandra Tucci,[...]. Blood 2006
160
23

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, P Felman, V Franco, E Iannitto, M Mollejo,[...]. Leukemia 2008
170
23

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
22

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
Marina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, Jane Gibson, Jun Wang, Renata Walewska, Helen Parker, Anton Parker, Zadie Davis, Anne Gardiner,[...]. Clin Cancer Res 2015
90
21

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Mark J Kiel, Thirunavukkarasu Velusamy, Bryan L Betz, Lili Zhao, Helmut G Weigelin, Mark Y Chiang, David R Huebner-Chan, Nathanael G Bailey, David T Yang, Govind Bhagat,[...]. J Exp Med 2012
202
19

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Marta Salido, Cristina Baró, David Oscier, Kostas Stamatopoulos, Judith Dierlamm, Estela Matutes, Alexandra Traverse-Glehen, Francoise Berger, Pascale Felman, Catherine Thieblemont,[...]. Blood 2010
117
17

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.
Carlos Montalbán, Víctor Abraira, Luca Arcaini, Eva Domingo-Domenech, Pablo Guisado-Vasco, Emilio Iannitto, Manuela Mollejo, Estella Matutes, Andrés Ferreri, Antonio Salar,[...]. Br J Haematol 2012
58
27

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Julien Lenglet, Catherine Traullé, Nicolas Mounier, Claire Benet, Nicolas Munoz-Bongrand, Sandy Amorin, Maria-Elena Noguera, Alexandra Traverse-Glehen, Martine Ffrench, Lucile Baseggio,[...]. Leuk Lymphoma 2014
53
30


Optimizing therapy for nodal marginal zone lymphoma.
Catherine Thieblemont, Thierry Molina, Frédéric Davi. Blood 2016
45
35

Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
Christina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, Sotirios Sachanas, Flora N Kontopidou, Xanthi Yiakoumis, Stella I Kokoris, Evagelia M Dimitriadou, Maria N Dimopoulou, Maria Moschogiannis,[...]. Oncologist 2013
58
25

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
N Martínez, C Almaraz, J P Vaqué, I Varela, S Derdak, S Beltran, M Mollejo, Y Campos-Martin, L Agueda, A Rinaldi,[...]. Leukemia 2014
80
17

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.
M Dreyling, C Thieblemont, A Gallamini, L Arcaini, E Campo, O Hermine, J C Kluin-Nelemans, M Ladetto, S Le Gouill, E Iannitto,[...]. Ann Oncol 2013
216
15

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
Olivier Hermine, François Lefrère, Jean-Pierre Bronowicki, Xavier Mariette, Katayoun Jondeau, Virginie Eclache-Saudreau, Béatrice Delmas, Françoise Valensi, Patrice Cacoub, Christian Brechot,[...]. N Engl J Med 2002
590
15


Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.
Ariela Noy, Sven de Vos, Catherine Thieblemont, Peter Martin, Christopher R Flowers, Franck Morschhauser, Graham P Collins, Shuo Ma, Morton Coleman, Shachar Peles,[...]. Blood 2017
180
15

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Zucca, L Arcaini, C Buske, P W Johnson, M Ponzoni, M Raderer, U Ricardi, A Salar, K Stamatopoulos, C Thieblemont,[...]. Ann Oncol 2020
99
15

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
A Clipson, M Wang, L de Leval, M Ashton-Key, A Wotherspoon, G Vassiliou, N Bolli, C Grove, S Moody, L Escudero-Ibarz,[...]. Leukemia 2015
110
14

The genetics of nodal marginal zone lymphoma.
Valeria Spina, Hossein Khiabanian, Monica Messina, Sara Monti, Luciano Cascione, Alessio Bruscaggin, Elisa Spaccarotella, Antony B Holmes, Luca Arcaini, Marco Lucioni,[...]. Blood 2016
95
14

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
Ajay K Gopal, Brad S Kahl, Sven de Vos, Nina D Wagner-Johnston, Stephen J Schuster, Wojciech J Jurczak, Ian W Flinn, Christopher R Flowers, Peter Martin, Andreas Viardot,[...]. N Engl J Med 2014
766
13

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Catherine Thieblemont, Pascale Felman, Francoise Berger, Charles Dumontet, Philippe Arnaud, Olivier Hequet, Josette Arcache, Evelyne Callet-Bauchu, Gilles Salles, Bertrand Coiffier. Clin Lymphoma 2002
112
13

Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.
Carlos Montalban, Victor Abraira, Luca Arcaini, Eva Domingo-Domenech, Pablo Guisado-Vasco, Emilio Iannitto, Manuela Mollejo, Estella Matutes, Andres J M Ferreri, Antonio Salar,[...]. Leuk Lymphoma 2014
24
50

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.
R Piva, S Deaglio, R Famà, R Buonincontri, I Scarfò, A Bruscaggin, E Mereu, S Serra, V Spina, D Brusa,[...]. Leukemia 2015
62
17

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
Andrea Rinaldi, Michael Mian, Ekaterina Chigrinova, Luca Arcaini, Govind Bhagat, Urban Novak, Paola M V Rancoita, Cassio P De Campos, Francesco Forconi, Randy D Gascoyne,[...]. Blood 2011
118
12

Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
Marina Parry, Matthew J J Rose-Zerilli, Jane Gibson, Sarah Ennis, Renata Walewska, Jade Forster, Helen Parker, Zadie Davis, Anne Gardiner, Andrew Collins,[...]. PLoS One 2013
55
20

Histologic transformation in marginal zone lymphomas†.
A Conconi, S Franceschetti, K Aprile von Hohenstaufen, G Margiotta-Casaluci, A Stathis, A A Moccia, F Bertoni, A Ramponi, L Mazzucchelli, F Cavalli,[...]. Ann Oncol 2015
54
20

An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
A James Watkins, Rifat A Hamoudi, Naiyan Zeng, Qingguo Yan, Yuanxue Huang, Hongxiang Liu, Jianzhong Zhang, Esteban Braggio, Rafael Fonseca, Laurence de Leval,[...]. PLoS One 2012
34
29

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Katharine H Xing, Amrit Kahlon, Brian F Skinnider, Joseph M Connors, Randy D Gascoyne, Laurie H Sehn, Kerry J Savage, Graham W Slack, Tamara N Shenkier, Richard Klasa,[...]. Br J Haematol 2015
40
25

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Apostolia M Tsimberidou, Daniel Catovsky, Ellen Schlette, Susan O'Brien, William G Wierda, Hagop Kantarjian, Guillermo Garcia-Manero, Sijin Wen, Kim-Anh Do, Susan Lerner,[...]. Cancer 2006
82
12

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Mathias J Rummel, Norbert Niederle, Georg Maschmeyer, G Andre Banat, Ulrich von Grünhagen, Christoph Losem, Dorothea Kofahl-Krause, Gerhard Heil, Manfred Welslau, Christina Balser,[...]. Lancet 2013
946
11

Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.
Tayse Silva Dos Santos, Renato Sampaio Tavares, Danielle Leão Cordeiro de Farias. Rev Bras Hematol Hemoter 2017
19
52

Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
Christina Kalpadakis, Gerassimos A Pangalis, Theodoros P Vassilakopoulos, Sotirios Sachanas, Maria K Angelopoulou. Leuk Lymphoma 2014
24
37

Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Maurilio Ponzoni, George Kanellis, Evi Pouliou, Panagiotis Baliakas, Lydia Scarfò, Andrés J M Ferreri, Claudio Doglioni, Vasilis Bikos, Antonis Dagklis, Achilles Anagnostopoulos,[...]. Am J Surg Pathol 2012
40
22

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Monica Else, Ana Marín-Niebla, Fátima de la Cruz, Paul Batty, Eduardo Ríos, Claire E Dearden, Daniel Catovsky, Estella Matutes. Br J Haematol 2012
50
18

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
Jennifer R Brown, Jonathan W Friedberg, Yang Feng, Sarah Scofield, Kimberly Phillips, Paola Dal Cin, Robin Joyce, Ronald W Takvorian, David C Fisher, Richard I Fisher,[...]. Br J Haematol 2009
61
14

A MALT lymphoma prognostic index.
Catherine Thieblemont, Luciano Cascione, Annarita Conconi, Barbara Kiesewetter, Markus Raderer, Gianluca Gaidano, Maurizio Martelli, Daniele Laszlo, Bertrand Coiffier, Armando Lopez Guillermo,[...]. Blood 2017
100
10

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
Emanuele Zucca, Annarita Conconi, Giovanni Martinelli, Reda Bouabdallah, Alessandra Tucci, Umberto Vitolo, Maurizio Martelli, Ruth Pettengell, Gilles Salles, Catherine Sebban,[...]. J Clin Oncol 2017
86
10

Splenic marginal zone lymphoma.
Miguel A Piris, Arantza Onaindía, Manuela Mollejo. Best Pract Res Clin Haematol 2017
21
42

Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
Jan Peveling-Oberhag, Franziska Wolters, Claudia Döring, Dirk Walter, Ludger Sellmann, René Scholtysik, Marco Lucioni, Max Schubach, Marco Paulli, Saskia Biskup,[...]. BMC Cancer 2015
26
30

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Davide Rossi, Silvia Deaglio, David Dominguez-Sola, Silvia Rasi, Tiziana Vaisitti, Claudio Agostinelli, Valeria Spina, Alessio Bruscaggin, Sara Monti, Michaela Cerri,[...]. Blood 2011
140
8

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
V Bikos, N Darzentas, A Hadzidimitriou, Z Davis, S Hockley, A Traverse-Glehen, P Algara, A Santoro, D Gonzalez, M Mollejo,[...]. Leukemia 2012
86
9

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Alberto J Arribas, Andrea Rinaldi, Afua A Mensah, Ivo Kwee, Luciano Cascione, Eloy F Robles, Jose A Martinez-Climent, David Oscier, Luca Arcaini, Luca Baldini,[...]. Blood 2015
37
21

Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Jose I Chacón, Manuela Mollejo, Enriqueta Muñoz, Patricia Algara, Marisol Mateo, Luis Lopez, Jesús Andrade, Iciar García Carbonero, Beatriz Martínez, Miguel A Piris,[...]. Blood 2002
120
8

Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
C Kalpadakis, G A Pangalis, M N Dimopoulou, T P Vassilakopoulos, M-C Kyrtsonis, P Korkolopoulou, F N Kontopidou, M P Siakantaris, E M Dimitriadou, S I Kokoris,[...]. Hematol Oncol 2007
70
11

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.
Emanuele Zucca, Annarita Conconi, Daniele Laszlo, Armando López-Guillermo, Reda Bouabdallah, Bertrand Coiffier, Catherine Sebban, Fabrice Jardin, Umberto Vitolo, Franck Morschhauser,[...]. J Clin Oncol 2013
154
8

2016 US lymphoid malignancy statistics by World Health Organization subtypes.
Lauren R Teras, Carol E DeSantis, James R Cerhan, Lindsay M Morton, Ahmedin Jemal, Christopher R Flowers. CA Cancer J Clin 2016
560
8

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
8

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Luca Arcaini, Caroline Besson, Marco Frigeni, Hélène Fontaine, Maria Goldaniga, Milvia Casato, Marcella Visentini, Harrys A Torres, Veronique Loustaud-Ratti, Jan Peveling-Oberhag,[...]. Blood 2016
113
8

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.
Christina Kalpadakis, Gerassimos A Pangalis, Sotirios Sachanas, Pantelis Tsirkinidis, Flora N Kontopidou, Maria Moschogiannis, Xanthi Yiakoumis, Efstathios Koulieris, Maria N Dimopoulou, Stella I Kokkoris,[...]. Blood 2018
26
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.